MammaPrint is a microarray-based commercialized assay that measures the 70 gene expressions and can predict the metastasis in ER/PR+/-, stage I or stage II, >5 cm, and three or fewer lymph nodes early-stage breast cancer [101]. The gene discussed is ESR1; the disease is breast carcinoma.